Furthermore, to investigate an association of stromal RUNX3 expression with the prognoses in breast cancer patients, tumor sections prepared from 241 breast cancer patients (Table 1) were stained with an anti‐RUNX3 antibody and subjected to tissue microarray analysis. Here, RUNX3 is linked to breast carcinoma.